Drug Spending on Accelerated Approval Indications Subsequently Withdrawn From the Market
This cross-sectional study examines spending on drugs with indications approved by the US Food and Drug Administration and withdrawn from the market from 2015 to 2024.
Authors
- Stacie B. Dusetzina (ORCID: https://orcid.org/0000-0002-3907-9196)
- Shelley A. Jazowski (ORCID: https://orcid.org/0000-0003-3467-2502)
Institutions
- Vanderbilt University (US)
- Vanderbilt-Ingram Cancer Center
- Wake Forest University Health Sciences (US)
- Wake Forest University (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2026-10-09
- DOI
- https://doi.org/10.1001/jamahealthforum.2026.3741
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00